Healthcor Management Lowers stake in Zimmer Biomet Holdings Inc (ZBH)

Zimmer Biomet Holdings Inc (ZBH) : Healthcor Management reduced its stake in Zimmer Biomet Holdings Inc by 33.33% during the most recent quarter end. The investment management company now holds a total of 1,000,000 shares of Zimmer Biomet Holdings Inc which is valued at $129,340,000 after selling 500,000 shares in Zimmer Biomet Holdings Inc , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Zimmer Biomet Holdings Inc makes up approximately 6.81% of Healthcor Management’s portfolio.

Other Hedge Funds, Including , First Allied Advisory Services reduced its stake in ZBH by selling 1,243 shares or 6.59% in the most recent quarter. The Hedge Fund company now holds 17,605 shares of ZBH which is valued at $2,277,031. Zimmer Biomet Holdings Inc makes up approx 0.12% of First Allied Advisory Services’s portfolio. M&r Capital Management Inc added ZBH to its portfolio by purchasing 1,855 company shares during the most recent quarter which is valued at $239,926. Zimmer Biomet Holdings Inc makes up approx 0.06% of M&r Capital Management Inc’s portfolio.Fukoku Mutual Life Insurance Co reduced its stake in ZBH by selling 300 shares or 15.79% in the most recent quarter. The Hedge Fund company now holds 1,600 shares of ZBH which is valued at $210,656. Zimmer Biomet Holdings Inc makes up approx 0.04% of Fukoku Mutual Life Insurance Co’s portfolio.Sit Investment Associates Inc reduced its stake in ZBH by selling 188,190 shares or 48.74% in the most recent quarter. The Hedge Fund company now holds 197,915 shares of ZBH which is valued at $25,954,573. Zimmer Biomet Holdings Inc makes up approx 0.67% of Sit Investment Associates Inc’s portfolio. Atalanta Sosnoff Capital added ZBH to its portfolio by purchasing 357,067 company shares during the most recent quarter which is valued at $43,804,980. Zimmer Biomet Holdings Inc makes up approx 1.42% of Atalanta Sosnoff Capital’s portfolio.

Zimmer Biomet Holdings Inc closed down -1.26 points or -0.97% at $128.35 with 9,65,288 shares getting traded on Thursday. Post opening the session at $129.5, the shares hit an intraday low of $128.06 and an intraday high of $129.97 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.

Investors should note that on Aug 23, 2016, Zimmer Biomet Holdings Inc announced a cash dividend of $0.2400. The company’s management has announced Sep 21, 2016 as the ex-dividend date and fixed the record date on Sep 23, 2016. The payable date has been fixed on Oct 28, 2016.

Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. SunTrust Initiated Zimmer Biomet Holdings Inc on Aug 11, 2016 to “Buy”, Price Target of the shares are set at $155.Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .

Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Zimmer Biomet Holdings Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zimmer Biomet Holdings Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.